Guizhou Sanli Pharmaceutical Co Ltd (603439) — Cash Flow Quality Index
Guizhou Sanli Pharmaceutical Co Ltd (603439) has a Cash Flow Quality Index of 0.78x as of June 2025. Operating cash flow of CN¥32.03 Million is below net income of CN¥41.11 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Guizhou Sanli Pharmaceutical Co Ltd asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guizhou Sanli Pharmaceutical Co Ltd Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Guizhou Sanli Pharmaceutical Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 603439 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Guizhou Sanli Pharmaceutical Co Ltd (2013–2024)
Year-by-year earnings quality comparison for Guizhou Sanli Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 603439 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.38x | CN¥107.07 Million | CN¥279.84 Million | ▼ -59.5% |
| 2023 | 0.95x | CN¥276.70 Million | CN¥292.70 Million | ▼ -38.1% |
| 2022 | 1.53x | CN¥293.29 Million | CN¥191.94 Million | ▲ +46.5% |
| 2021 | 1.04x | CN¥155.04 Million | CN¥148.60 Million | ▲ +55.0% |
| 2020 | 0.67x | CN¥63.25 Million | CN¥93.95 Million | ▼ -22.9% |
| 2019 | 0.87x | CN¥116.24 Million | CN¥133.07 Million | ▲ +28.1% |
| 2018 | 0.68x | CN¥75.35 Million | CN¥110.48 Million | ▲ +4.0% |
| 2017 | 0.66x | CN¥57.47 Million | CN¥87.63 Million | ▲ +39.9% |
| 2016 | 0.47x | CN¥35.10 Million | CN¥74.88 Million | ▼ -25.9% |
| 2015 | 0.63x | CN¥33.28 Million | CN¥52.61 Million | ▲ +3154.9% |
| 2014 | 0.02x | CN¥563.46K | CN¥28.99 Million | ▼ -98.7% |
| 2013 | 1.55x | CN¥30.09 Million | CN¥19.37 Million | — |